Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-000673

Chief Executive Officer sold 11,520 shares at $19.05 ($219,456)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-02 Sale : show line 1 in the form 10b5-1 −11,520 $19.05 $219,456 3,764,252 D
Open-market sales · 11,520 sh · avg $19.05 · $219,456
Loading xslF345X05/wk-form4_1736204845.xml…